Abstract
This article provides the latest information on the history of hypertension, the types of the disease, and effective ways to prevent and treat hypertension.
References
1. ^ Jump up to:a b c d e f "About High Blood Pressure". Centers for Disease Control and Prevention (CDC). 15 May 2024. Archived from the original on 20 May 2024. Retrieved 22 May 2024.
2. ^ Jump up to:a b c Lackland DT, Weber MA (May 2015). "Global burden of cardiovascular disease and stroke: hypertension at the core". The Canadian Journal of Cardiology. 31 (5): 569–571. doi:10.1016/j.cjca.2015.01.009. PMID 25795106.
3. ^ Jump up to:a b Mendis S, Puska P, Norrving B (2011). Global atlas on cardiovascular disease prevention and control (PDF) (1st ed.). Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. p. 38. ISBN 978-92-4-156437-3. Archived from the original (PDF) on 17 August 2014.
4. ^ Jump up to:a b Hernandorena I, Duron E, Vidal JS, Hanon O (July 2017). "Treatment options and considerations for hypertensive patients to prevent dementia". Expert Opinion on Pharmacotherapy (Review). 18 (10): 989–1000. doi:10.1080/14656566.2017.1333599. PMID 28532183. S2CID 46601689.
5. ^ Jump up to:a b c d e f g h i j k Poulter NR, Prabhakaran D, Caulfield M (August 2015). "Hypertension". Lancet. 386 (9995): 801–812. doi:10.1016/s0140-6736(14)61468-9. PMID 25832858. S2CID 208792897.
6. ^ Jump up to:a b c d e f g h i Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT (June 2018). "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Hypertension. 71 (6): e13 – e115. doi:10.1161/HYP.0000000000000065. PMID 29133356.
7. ^ Jump up to:a b c d e f g h i j k l m n o p q Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, et al. (1 December 2023). "2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)". Journal of Hypertension. 41 (12): 1874–2071. doi:10.1097/HJH.0000000000003480. hdl:11379/603005. ISSN 1473-5598. PMID 37345492.
8. ^ Jump up to:a b c "How Is High Blood Pressure Treated?". National Heart, Lung, and Blood Institute. 10 September 2015. Archived from the original on 6 April 2016. Retrieved 6 March 2016.
9. ^ Jump up to:a b c d e f g h i j k Global report on hypertension: the race against a silent killer. Geneva: World Health Organization (WHO). 19 September 2023. ISBN 978-92-4-008106-2.
10. ^ Jump up to:a b c d e f g Ezzati M, Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, et al. (NCD Risk Factor Collaboration) (11 September 2021). "Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants". The Lancet. 398 (10304): 957–980. doi:10.1016/S0140-6736(21)01330-1. ISSN 0140-6736. PMC 8446938. PMID 34450083. S2CID 237286310.
11. ^ Jump up to:a b Naish J, Court DS (2014). Medical sciences (2 ed.). Elsevier Health Sciences. p. 562. ISBN 978-0-7020-5249-1.
12. ^ Jump up to:a b Lau DH, Nattel S, Kalman JM, Sanders P (August 2017). "Modifiable Risk Factors and Atrial Fibrillation". Circulation (Review). 136 (6): 583–596. doi:10.1161/CIRCULATIONAHA.116.023163. PMID 28784826.
13. ^ Jump up to:a b c d e f "Hypertension". World Health Organization (WHO). 16 March 2023. Retrieved 22 May 2024.
14. ^ Jump up to:a b c d e f James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC, Svetkey LP, Taler SJ, Townsend RR, Wright JT, Narva AS, Ortiz E (February 2014). "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–520. doi:10.1001/jama.2013.284427. PMID 24352797.
15. ^ Musini VM, Tejani AM, Bassett K, Puil L, Wright JM (June 2019). "Pharmacotherapy for hypertension in adults 60 years or older". The Cochrane Database of Systematic Reviews. 6 (6): CD000028. doi:10.1002/14651858.CD000028.pub3. PMC 6550717. PMID 31167038.
16. ^ Sundström J, Arima H, Jackson R, Turnbull F, Rahimi K, Chalmers J, Woodward M, Neal B (February 2015). "Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis". Annals of Internal Medicine. 162 (3): 184–191. doi:10.7326/M14-0773. PMID 25531552. S2CID 46553658.
17. ^ Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A (January 2016). "Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis". Lancet. 387 (10017): 435–443. doi:10.1016/S0140-6736(15)00805-3. PMID 26559744. S2CID 36805676. Archived from the original on 16 April 2019. Retrieved 11 February 2019.
18. ^ Diao D, Wright JM, Cundiff DK, Gueyffier F (August 2012). "Pharmacotherapy for mild hypertension". The Cochrane Database of Systematic Reviews. 8 (8): CD006742. doi:10.1002/14651858.CD006742.pub2. PMC 8985074. PMID 22895954. S2CID 42363250.
19. ^ Garrison SR, Kolber MR, Korownyk CS, McCracken RK, Heran BS, Allan GM (August 2017). "Blood pressure targets for hypertension in older adults". The Cochrane Database of Systematic Reviews. 2017 (8): CD011575. doi:10.1002/14651858.CD011575.pub2. PMC 6483478. PMID 28787537.
20. ^ Musini VM, Gueyffier F, Puil L, Salzwedel DM, Wright JM (August 2017). "Pharmacotherapy for hypertension in adults aged 18 to 59 years". The Cochrane Database of Systematic Reviews. 2017 (8): CD008276. doi:10.1002/14651858.CD008276.pub2. PMC 6483466. PMID 28813123.
21. ^ Jump up to:a b Fisher ND, Williams GH (2005). "Hypertensive vascular disease". In Kasper DL, Braunwald E, Fauci AS, et al. (eds.). Harrison's Principles of Internal Medicine (16th ed.). New York: McGraw-Hill. pp. 1463–1481. ISBN 978-0-07-139140-5.
22. ^ Marshall IJ, Wolfe CD, McKevitt C (July 2012). "Lay perspectives on hypertension and drug adherence: systematic review of qualitative research". The BMJ. 345: e3953. doi:10.1136/bmj.e3953. PMC 3392078. PMID 22777025.
23. ^ Wong TY, Wong T, Mitchell P (February 2007). "The eye in hypertension". Lancet. 369 (9559): 425–435. doi:10.1016/S0140-6736(07)60198-6. PMID 17276782. S2CID 28579025.
24. ^ "Truncal obesity (Concept Id: C4551560) – MedGen – NCBI". ncbi.nlm.nih.gov. Retrieved 24 April 2022.
25. ^ Jump up to:a b c d e f g h i j k l m O'Brien E, Beevers DG, Lip GY (2007). ABC of hypertension. London: BMJ Books. ISBN 978-1-4051-3061-5.
26. ^ "High Blood Pressure – Understanding the Silent Killer". Center for Drug Evaluation and Research. U.S. Food and Drug Administration. 21 January 2021.

This work is licensed under a Creative Commons Attribution 4.0 International License.
